SS Innovations (SSII) Q2 2024 Earnings Report

SS Innovations International Inc (SSII) reported QQ2 2024 results with a pronounced top-line increase but a challenging earnings trajectory consistent with a growth-stage healthcare robotics company. Revenue reached $4.39 million, up 178% year-over-year from $1.58 million in QQ2 2023, signaling early traction for the company’s robotic platforms (SSI Mantra, Mudra, Maya) and the OMNI 3D HD viewing system. Despite the revenue uplift, profitability remained negative, with EBITDA of -$2.40 million and net income of -$2.93 million, as operating expenses (notably SG&A of $3.48 million) and modest R&D outlays continued to outpace gross profit of $0.74 million (gross margin 16.8%). Net loss per share stood at -$0.0172 on a diluted basis, underscoring ongoing burn and development costs typical of a pre-commercial-stage medical device company.